Report copyright - Preliminary Results From a Phase I Dose Escalation Trial ......Preliminary Results From a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis
Please pass captcha verification before submit form